Marrone Bio Innovations, Inc. (MBII) specializes in the creation, development, and commercialization of biologically-derived products for use in agriculture. The company's product line is strategically designed to bolster crop protection, improve overall plant vitality, and provide essential nutrition for various crops. Their extensive portfolio includes solutions such as Emergen, Foramin (and its ST variant), Optima, Takla, Pacesetter, Ympact, and UBP (and its ST variant), all engineered to enhance crop health, maximize yields, and improve the final quality of produce. For pest control, MBII offers Grandevo, a bioinsecticide that targets sucking and chewing insects, and Venerate, another bioinsecticide effective against a range of chewing and sucking insects, as well as mites. To combat environmental stressors, Haven is available as a plant health product formulated to reduce sun-induced stress and combat dehydration. Furthermore, their Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers play a crucial role in preventing, managing, and eliminating algal, fungal, and bacterial diseases throughout both the agricultural and horticultural sectors. The company also supplies bionematicides like Majestene, which controls soil-dwelling nematodes and certain soil-borne insects, and Zelto, specifically formulated to protect turf areas, including golf course fairways and greens, by promoting robust plant and root health. Rounding out their offerings are Regalia and Stargus, products that deliver defense against fungal and bacterial diseases while concurrently boosting crop yields and quality. Marrone Bio Innovations distributes its offerings through a blended approach, employing a direct sales force in addition to working with distributors and various commercial partners. The company, initially incorporated in 2006 under the name Marrone Organic Innovations, Inc., is headquartered in Raleigh, North Carolina.


Net sales
Gross margin
Net income